Variability of bothersome menopausal symptoms over time - a longitudinal analysis using the Estonian postmenopausal hormone therapy trial (EPHT)

BMC Women's Health

Volumn 12, Issue , 2012, Pages

  Hemminki, Elina ^a   Regushevskaya, Elena ^a   Luoto, Riitta ^a   Veerus, Piret ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

Author keywords

Duration; Estonia; Follow up; Menopausal symptoms

Indexed keywords

HORMONE; PLACEBO;

ADULT; ARTICLE; BOTHERSOMENESS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; ESTONIAN POSTMENOPAUSAL HORMONE THERAPY; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; VASOMOTOR DISORDER;

DRUG THERAPY, COMBINATION; ESTONIA; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; FOLLOW-UP STUDIES; HOT FLASHES; HUMANS; LONGITUDINAL STUDIES; MEDROXYPROGESTERONE ACETATE; MENOPAUSE; MIDDLE AGED; POSTMENOPAUSE; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; SELF-ASSESSMENT; SOCIOECONOMIC FACTORS; VASOMOTOR SYSTEM; WOMEN'S HEALTH;

EID: 84871384931     PISSN: None     EISSN: 14726874     Source Type: Journal    
DOI: 10.1186/1472-6874-12-44     Document Type: Article

References (26)

1. Hemminki E, Topo P, Kangas I. Experience and opinions of climacterium by Finnish women. Eur J of Obstet Gyn Rep Bio 1995, 62:81-87.
2. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000, 96:351-358. 10.1016/S0029-7844(00)00930-3, 10960625.
3. Samsioe G, Dören M, Lobo RA. Acute symptoms of the menopause. Women's health med 2006, 3:282-286. 10.1016/S1744-1870(07)70010-0, 23301221.
4. Funmilola OM, Taiwo LO. Experience of menopausal symptoms by women in an urban community in Ibadan, Nigeria. Menopause 2008, 16:1-9.
5. Rödström K, Bengtsson C, Lissner L, Milsom I, Sundh V, Björkelund C. A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century. Menopause 2002, 9:156-161. 10.1097/00042192-200205000-00003, 11973438.
6. National Institutes of Health state of science conference statement on management of menopause-related symptoms 2005, NIH, http://consensus.nih.gov/ [accessed 23.02.2011], National Institutes of Health state of science conference statement on management of menopause-related symptoms.
7. Oldenhave A, Netelenbos C. Pathogenesis of climacteric complaints: ready for the change?. Lancet 1994, 343:649-653. 10.1016/S0140-6736(94)92641-7, 7906816.
8. Oldenhave A, Jaszmann LJB, Haspels AA, Everaerd WT. Impact of climacteric on well-being: a survey based on 5213 women 39 to 60 years old. Am J Obstet Gynecol 1993, 168:772-780.
9. Holte A. Prevalence of climacteric complaints in a representative sample of middle-aged women in Oslo, Norway. J Psycosom Obstet Gynaecol 1991, 12:303-317.
10. Stearns V, Ullmer L, Lopez JF, Smith J, Isaacs C, Hayes DF. Hot flushes. Lancet 2002, 360:1851-1861. 10.1016/S0140-6736(02)11774-0, 12480376.
11. Bardel A, Wallander MA, Svarsudd K. Hormone replacement therapy and symptom reporting in menopausal women. A population-based study of 35-65-year-old women in mid-Sweden. Maturitas 2002, 41:7-15. 10.1016/S0378-5122(01)00254-7, 11809338.
12. Kronenberg F. Hot flashes: epidemiology and physiology. Ann NY Acad Sci 1990, 592:52-86. 10.1111/j.1749-6632.1990.tb30316.x, 2197954.
13. Politi MC, Schleinitz MD, Col NF. Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis. J Gen Intern Med 2008, 23:1507-1513. 10.1007/s11606-008-0655-4, 2518020, 18521690.
14. Avis NE, Colvin A, Bromnerger JT, Hess R, Matthews KA, Ory M, Schocken M. Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women: study of women's health across the nations. Manopause 2009, 16:860-869.
15. Blumel JE, Chedraui P, Baron J, Belzares E, Bemcosme A, Calle A, et al. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women. Menopause 2011, 18:778-785. 10.1097/gme.0b013e318207851d, 21407137.
16. Brown WJ, Mishra GD, Dobson A. Changes in physical symptoms during the menopause transition. Int J Behav Med 2002, 9:53-67. 10.1207/S15327558IJBM0901_04, 12112996.
17. Porter M, Penney GC, Russell D, Russell E, Templeton A. A population based survey of women's experience of the menopause. Br J Obstet Gynaecol 1996, 103:1025-1028. 10.1111/j.1471-0528.1996.tb09555.x, 8863703.
18. Mitchell ES, Woods NF. Symptom experiences of midlife women: observations from the Seattle midlife women's health study. Maturitas 1996, 25:1-10. 10.1016/0378-5122(96)01047-X, 8887303.
19. Jokinen K, Rautava P, Mäkinen J, Ojanlatva A, Sundell J, Helenius H. Experience of climacteric symptoms among 42-46 and 52-56-year-old women. Maturitas 2003, 46:199-205. 10.1016/S0378-5122(03)00216-0, 14585522.
20. Col NF, Guthrie JR, Politi M, Dennerstein L. Duration of vasomotor symptoms in middle-aged women: a longitudinal study. Menopause 2009, 16:453-457. 10.1097/gme.0b013e31818d414e, 19188852.
21. Veerus P, Hovi S-L, Fischer K, Rahu M, Hakama M, Hemminki E. Results from the Estonian postmenopausal hormone therapy trial. Maturitas 2006, 55:162-173. 10.1016/j.maturitas.2006.01.012, 16504428.
22. Veerus P, Fischer K, Hovi SL, Hakama M, Rahu M, Hemminki E. Postmenopausal hormone therapy increases use of health services: experience from the Estonian postmenopausal hormone therapy trial [ISRCTN35338757]. Am J Obstet Gynecol 2006, 195:62-71. 10.1016/j.ajog.2005.12.037, 16813745.
23. Veerus P, Fischer K, Hovi SL, Karro H, Hemminki E. Does hormone replacement therapy affect the use of prescription medicines in postmenopausal women: experience from the Estonian postmenopausal hormone therapy trial [ISRCTN35338757]. BJOG 2007, 114:548-554. 10.1111/j.1471-0528.2007.01292.x, 17355268.
24. Vorobjov S, Hovi SL, Veerus P, Pisarev H, Rahu M, Hemminki E. Treatment adherence in the Estonian postmenopausal hormone therapy (EPHT) trial [ISRCTN35338757]. Maturitas 2005, 52:286-295. 10.1016/j.maturitas.2005.05.001, 16055284.
25. Hovi S-L, Hakama M, Veerus P, Rahu M, Hemminki E. Who wants to join preventive trials? - experience from the Estonian postmenopausal hormone therapy trial [ISRCTN35338757]. BMC Med Res Methodol 2005, 5:12. http://www.biomedcentral.com/1471-2288/5/12 [accessed 23.02.2011], 10.1186/1471-2288-5-12, 1090584, 15826311.
26. Chlebowski RT, Anderson GL, Manson JE, Schwartz AG, Wakelee H, Gass M, et al. Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial. J Natl Cancer Inst 2010, 102(18):1413-1421. 10.1093/jnci/djq285, 2943522, 20709992.